Virus reactivations and serology patterns following first-line therapy with alemtuzumab or fludarabine-based combination therapy in patients with chronic lymphocytic leukemia

Detalles Bibliográficos
Autores principales: Karlsson, C, Dahl, H, Lundin, J, Rossmann, E, Brytting, M, Mellstedt, H, Linde, A, Österborg, A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2011
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3255266/
https://www.ncbi.nlm.nih.gov/pubmed/22829166
http://dx.doi.org/10.1038/bcj.2011.20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3255266/
https://www.ncbi.nlm.nih.gov/pubmed/22829166
http://dx.doi.org/10.1038/bcj.2011.20

Ejemplares similares